Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Kröger, Nicolaus"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 73
Tytuł:
Development and Validation of a Concise Objectifiable Risk Evaluation Score for Non-Relapse Mortality after Allogeneic Hematopoietic Stem Cell Transplantation.
Autorzy:
Weise G; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20251 Hamburg, Germany.
Massoud R; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20251 Hamburg, Germany.
Krause R; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20251 Hamburg, Germany.
Heidenreich S; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20251 Hamburg, Germany.
Janson D; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20251 Hamburg, Germany.
Klyuchnikov E; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20251 Hamburg, Germany.
Wolschke C; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20251 Hamburg, Germany.
Zeck G; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20251 Hamburg, Germany.
Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20251 Hamburg, Germany.
Ayuk F; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20251 Hamburg, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2024 Jan 25; Vol. 16 (3). Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CD45-Directed CAR-T Cells with CD45 Knockout Efficiently Kill Myeloid Leukemia and Lymphoma Cells In Vitro Even after Extended Culture.
Autorzy:
Harfmann M; Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Centre Hamburg-Eppendorf (UKE), 20246 Hamburg, Germany.
Schröder T; Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Centre Hamburg-Eppendorf (UKE), 20246 Hamburg, Germany.
Głów D; Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Centre Hamburg-Eppendorf (UKE), 20246 Hamburg, Germany.
Jung M; Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Centre Hamburg-Eppendorf (UKE), 20246 Hamburg, Germany.
Uhde A; Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Centre Hamburg-Eppendorf (UKE), 20246 Hamburg, Germany.
Kröger N; Department of Stem Cell Transplantation, University Medical Centre Hamburg-Eppendorf (UKE), 20246 Hamburg, Germany.
Horn S; Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Centre Hamburg-Eppendorf (UKE), 20246 Hamburg, Germany.
Riecken K; Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Centre Hamburg-Eppendorf (UKE), 20246 Hamburg, Germany.
Fehse B; Research Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Centre Hamburg-Eppendorf (UKE), 20246 Hamburg, Germany.
Ayuk FA; Department of Stem Cell Transplantation, University Medical Centre Hamburg-Eppendorf (UKE), 20246 Hamburg, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2024 Jan 12; Vol. 16 (2). Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Health-Related Quality of Life in Multiple Myeloma Patients Treated with High- or Low-Dose Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation-Results from the LenaMain Trial (NCT00891384).
Autorzy:
Boquoi A; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, 40225 Duesseldorf, Germany.
Giagounidis A; Klinik für Onkologie, Hämatologie und Palliativmedizin, Marien Hospital Düsseldorf, Rochusstr. 2, 40479 Düsseldorf, Germany.
Goldschmidt H; National Center for Tumor Diseases Heidelberg (NCT), 69120 Heidelberg, Germany.; Department of Internal Medicine V, University of Heidelberg, 69120 Heidelberg, Germany.
Heinsch M; Helios Klinikum Duisburg, 47166 Duisburg, Germany.
Rummel MJ; Medizinische Klinik IV, University Hospital, 35392 Giessen, Germany.
Kröger N; University Hospital Eppendorf, 20251 Hamburg, Germany.
Mai EK; Department of Medicine V, Hematology, Oncology and Rheumatology, University of Heidelberg, 69120 Heidelberg, Germany.
Strapatsas J; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, 40225 Duesseldorf, Germany.
Haas R; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, 40225 Duesseldorf, Germany.
Kobbe G; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, 40225 Duesseldorf, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Oct 26; Vol. 15 (21). Date of Electronic Publication: 2023 Oct 26.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Use of ropeginterferon in inducing graft versus myelofibrosis effect in post-transplant myelofibrosis relapse.
Autorzy:
Srivastava B; Epworth Hospital Melbourne Australia.; Department of Stem Cell Transplantation University Medical Center Hamburg-Eppendorf Hamburg Germany.
Wolschke C; Department of Stem Cell Transplantation University Medical Center Hamburg-Eppendorf Hamburg Germany.
Gagelmann N; Department of Stem Cell Transplantation University Medical Center Hamburg-Eppendorf Hamburg Germany.
Badbaran A; Department of Stem Cell Transplantation University Medical Center Hamburg-Eppendorf Hamburg Germany.
Kröger N; Department of Stem Cell Transplantation University Medical Center Hamburg-Eppendorf Hamburg Germany.
Pokaż więcej
Źródło:
Clinical case reports [Clin Case Rep] 2023 Sep 21; Vol. 11 (9), pp. e7942. Date of Electronic Publication: 2023 Sep 21 (Print Publication: 2023).
Typ publikacji:
Case Reports
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Abdominal emergency surgery in patients with hematological malignancies: a retrospective single-center analysis.
Autorzy:
von Kroge PH; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. .
Duprée A; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Mann O; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Izbicki JR; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Wagner J; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Ahmadi P; Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.; Department of Medical Psychology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Weidemann S; Institute of Pathology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Adjallé R; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Bokemeyer C; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Fiedler W; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Modemann F; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.; Mildred Scheel Cancer Career Center, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Ghandili S; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Pokaż więcej
Źródło:
World journal of emergency surgery : WJES [World J Emerg Surg] 2023 Feb 06; Vol. 18 (1), pp. 12. Date of Electronic Publication: 2023 Feb 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Intestinal Obstruction*/etiology
Intestinal Obstruction*/surgery
Cholecystitis, Acute*/etiology
Humans ; Retrospective Studies ; Anastomosis, Surgical ; Anastomotic Leak/etiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Individualized busulfan dosing improves outcomes compared to fixed-dose administration in pre-transplant minimal residual disease-positive acute myeloid leukemia patients with intermediate-risk undergoing allogeneic stem cell transplantation in CR.
Autorzy:
Klyuchnikov E; Department of Stem Cell Transplantation, University Medical Center Eppendorf, University of Hamburg, Hamburg, Germany.
Langebrake C; Department of Stem Cell Transplantation, University Medical Center Eppendorf, University of Hamburg, Hamburg, Germany.; Hospital Pharmacy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Badbaran A; Department of Stem Cell Transplantation, University Medical Center Eppendorf, University of Hamburg, Hamburg, Germany.
Dadkhah A; Department of Stem Cell Transplantation, University Medical Center Eppendorf, University of Hamburg, Hamburg, Germany.; Hospital Pharmacy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Massoud R; Department of Stem Cell Transplantation, University Medical Center Eppendorf, University of Hamburg, Hamburg, Germany.
Freiberger P; Department of Stem Cell Transplantation, University Medical Center Eppendorf, University of Hamburg, Hamburg, Germany.
Ayuk F; Department of Stem Cell Transplantation, University Medical Center Eppendorf, University of Hamburg, Hamburg, Germany.
Janson D; Department of Stem Cell Transplantation, University Medical Center Eppendorf, University of Hamburg, Hamburg, Germany.
Wolschke C; Department of Stem Cell Transplantation, University Medical Center Eppendorf, University of Hamburg, Hamburg, Germany.
Bacher U; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, Bern, Switzerland.
Kröger N; Department of Stem Cell Transplantation, University Medical Center Eppendorf, University of Hamburg, Hamburg, Germany.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2023 Feb; Vol. 110 (2), pp. 188-197. Date of Electronic Publication: 2022 Dec 01.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/adverse effects
Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/therapy
Leukemia, Myeloid, Acute*/etiology
Graft vs Host Disease*/diagnosis
Graft vs Host Disease*/etiology
Graft vs Host Disease*/prevention & control
Humans ; Busulfan/adverse effects ; Neoplasm, Residual ; Transplantation, Homologous ; Recurrence ; Transplantation Conditioning ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Higher risk for chronic graft-versus-host disease (GvHD) in HLA-G mismatched transplants following allogeneic hematopoietic stem cell transplantation: A retrospective study.
Autorzy:
Neuchel C; Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg - Hessen, Ulm, University Hospital of Ulm, Ulm, Germany.; Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.
Gowdavally S; Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg - Hessen, Ulm, University Hospital of Ulm, Ulm, Germany.; Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.
Tsamadou C; Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg - Hessen, Ulm, University Hospital of Ulm, Ulm, Germany.; Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.
Platzbecker U; Department of Hematology/Oncology, University of Leipzig, Leipzig, Germany.
Sala E; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
Wagner-Drouet E; Department of Medicine III, Johannes Gutenberg-University of Mainz, Mainz, Germany.
Valerius T; Section for Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian Albrechts University, Kiel, Germany.
Kröger N; Department of Stem Cell Transplantation, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
Wulf G; Department of Hematology/Oncology, Georg-August-University Göttingen, Göttingen, Germany.
Einsele H; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
Thurner L; Department Internal Medicine I, Universitätsklinikum des Saarlandes, Homburg, Germany.
Schaefer-Eckart K; Medical Clinic 5: Hematology, Oncology, Nuremberg Hospital, Nuremberg, Germany.
Freitag S; Department of Medicine III, Hematology/Oncology/Palliative Care, Rostock University Medical Center, Rostock, Germany.
Casper J; Department of Oncology and Hematology, Klinikum Oldenburg, University Clinic, Oldenburg, Germany.
Dürholt M; Hematology/Oncology, Evangelic Clinic Essen-Werden, Essen, Germany.
Kaufmann M; 2nd Department of Internal Medicine, Oncology and Hematology, Robert Bosch Hospital, Stuttgart, Germany.
Hertenstein B; Hematology/Oncology, Klinikum Bremen-Mitte, Bremen, Germany.
Klein S; Universitätsmedizin Mannheim, Med. Klinik III, Mannheim, Germany.
Ringhoffer M; Medizinische Klinik III, Städtisches Klinikum, Karlsruhe, Germany.
Frank S; DRST - Deutsches Register für Stammzelltransplantation, German Registry for Stem Cell Transplantation, Ulm, Germany.
Amann EM; Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg - Hessen, Ulm, University Hospital of Ulm, Ulm, Germany.; Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.
Rode I; Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg - Hessen, Ulm, University Hospital of Ulm, Ulm, Germany.; Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.
Schrezenmeier H; Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg - Hessen, Ulm, University Hospital of Ulm, Ulm, Germany.; Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.
Mytilineos J; DRST - Deutsches Register für Stammzelltransplantation, German Registry for Stem Cell Transplantation, Ulm, Germany.; ZKRD - Zentrales Knochenmarkspender-Register für Deutschland, German National Bone Marrow Donor Registry, Ulm, Germany.
Fürst D; Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg - Hessen, Ulm, University Hospital of Ulm, Ulm, Germany.; Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.
Pokaż więcej
Źródło:
HLA [HLA] 2022 Oct; Vol. 100 (4), pp. 349-360. Date of Electronic Publication: 2022 Jul 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/methods
Leukemia, Myeloid, Acute*
Alleles ; HLA-G Antigens ; Humans ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Complications of Autologous Stem Cell Transplantation in Multiple Myeloma: Results from the CALM Study.
Autorzy:
Waszczuk-Gajda A; Department of Hematology, Transplantation and Internal Medicine, University Clinical Centre-The Medical University of Warsaw, 02-097 Warsaw, Poland.
Penack O; Charité Universitätsmedizin Berlin, 10771 Berlin, Germany.
Sbianchi G; Tor Vergata University, 00133 Rome, Italy.
Koster L; EBMT Data Office Leiden, 2333 AA Leiden, The Netherlands.
Blaise D; Institut Paoli Calmettes, 13009 Marseille, France.
Reményi P; Dél-Pesti Centrumkórház, 1097 Budapest, Hungary.
Russell N; Nottingham University, Nottingham NG7 2QL, UK.
Ljungman P; Department of Cellular Therapy and Allogeneic Stem Cell Transplantation, Karolinska Comprehensive Cancer Center, Karolinska University Hospital Huddinge, 17177 Stockholm, Sweden.; Division of Hematology, Department of Medicine Huddinge, Karolinska Institute, 171 77 Stockholm, Sweden.
Trneny M; University Hospital, 12808 Prague, Czech Republic.
Mayer J; University Hospital Brno, 62500 Brno, Czech Republic.
Iacobelli S; Tor Vergata University, 00133 Rome, Italy.
Kobbe G; Heinrich Heine Universitaet, 40225 Duesseldorf, Germany.
Scheid C; University of Cologne, 50923 Cologne, Germany.
Apperley J; Imperial College, London SW7-2BX, UK.
Touzeau C; CHU Nantes, 44000 Nantes, France.
Lenhoff S; Skanes University Hospital, 23262 Lund, Sweden.
Jantunen E; Department of Medicine, University of Eastern Finland and Hospital District of North Carelia, Kuopio University Hospital, 70211 Kuopio, Finland.
Anagnostopoulos A; George Papanicolaou General Hospital, 57010 Thessaloniki, Greece.
Paris L; Division of Hematology, SST Papa Giovanni XXIII, 24127 Bergamo, Italy.
Browne P; Hope Directorate, D08 NHY1 Dublin, Ireland.
Thieblemont C; Hôpital St. Louis, 75010 Paris, France.
Schaap N; Radboud University Medical Centre, Department of Hematology, 6525 GA Nijmegen, The Netherlands.
Sierra J; Hospital Santa Creu i Sant Pau, 08001 Barcelona, Spain.
Yakoub-Agha I; CHU de Lille, 59000 Lille, France.
Garderet L; Centre de Recherche Saint-Antoine, Sorbonne Université-INSERM, UMR_S 938, 75013 Paris, France.; Département d'Hématologie et de Thérapie Cellulaire, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié Salpetrière, 75012 Paris, France.
Styczynski J; Department of Pediatric Hematology and Oncology, Collegium Medicum UMK, 85-067 Bydgoszcz, Poland.
Schoemans H; Department of Hematology, University Hospitals Leuven, 3000 Leuven, Belgium.; Department of Public Health and Primary Care, ACCENT VV, KU Leuven-University of Leuven, 3000 Leuven, Belgium.
Moiseev I; R.M. Gorbacheva Memorial Institute of Hematology, Oncology and Transplantation, Pavlov University, 197022 Saint-Petersburg, Russia.
Duarte RF; Hospital Universitario Puerta de Hierro Majadahonda-Universidad Autónoma de Madrid, 28222 Madrid, Spain.
Peric Z; Department of Internal Medicine, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia.
Montoto S; Department of Haemato-Oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London EC1A 7BE, UK.
van Biezen A; EBMT Data Office Leiden, 2333 AA Leiden, The Netherlands.
Mikulska M; Division of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genoa, 16121 Genoa, Italy.; Division of Infectious Diseases, IRC CS Ospedale Policlinico San Martino, 16132 Genoa, Italy.
Aljurf M; Section of Adult Haematolgy/BMT, King Faisal Specialist Hospital & Research Centre Oncology, Riyadh 11564, Saudi Arabia.
Ruutu T; Comprehensive Cancer Center, Department of Hematology, Helsinki University Hospital and University of Helsinki, 00290 Helsinki, Finland.; Clinical Research Institute, Helsinki University Hospital and University of Helsinki, 00280 Helsinki, Finland.
Kröger N; University Hospital Eppendorf, 20246 Hamburg, Germany.
Morris C; Belfast City Hospital, Belfast BT9 7AB, UK.
Koenecke C; Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 30625 Hannover, Germany.
Schoenland S; Department of Internal Medicine V, Division of Hematology/Oncology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Basak GW; Department of Hematology, Transplantation and Internal Medicine, University Clinical Centre-The Medical University of Warsaw, 02-097 Warsaw, Poland.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2022 Jun 20; Vol. 11 (12). Date of Electronic Publication: 2022 Jun 20.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Detection of human herpesvirus 6 DNA and chromosomal integration after allogeneic hematopoietic stem cell transplantation: A retrospective single center analysis.
Autorzy:
Berneking L; Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Both A; Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Langebrake C; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Hospital Pharmacy, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Aepfelbacher M; Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Lütgehetmann M; Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Christopeit M; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Medical Clinic, Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany.
Pokaż więcej
Źródło:
Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2022 Jun; Vol. 24 (3), pp. e13836. Date of Electronic Publication: 2022 May 08.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/adverse effects
Herpesvirus 6, Human*/genetics
Roseolovirus Infections*/diagnosis
Roseolovirus Infections*/drug therapy
Roseolovirus Infections*/epidemiology
Adult ; DNA, Viral/genetics ; Humans ; Retrospective Studies ; Virus Integration
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Population Pharmacokinetics of Busulfan and Its Metabolite Sulfolane in Patients with Myelofibrosis Undergoing Hematopoietic Stem Cell Transplantation.
Autorzy:
Dadkhah A; Hospital Pharmacy, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Wicha SG; Department of Clinical Pharmacy, Institute of Pharmacy, University of Hamburg, 20146 Hamburg, Germany.
Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Müller A; Department of Legal Medicine, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Pfaffendorf C; Department of Clinical Pharmacy, Institute of Pharmacy, University of Hamburg, 20146 Hamburg, Germany.
Riedner M; Technology Platform Mass Spectrometry, University of Hamburg, 20146 Hamburg, Germany.
Badbaran A; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Fehse B; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Langebrake C; Hospital Pharmacy, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Pokaż więcej
Źródło:
Pharmaceutics [Pharmaceutics] 2022 May 27; Vol. 14 (6). Date of Electronic Publication: 2022 May 27.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemia.
Autorzy:
Al Hamed R; Department of Internal Medicine, Jacobi Medical Center/Albert Einstein College of Medicine, Bronx, New York, USA.
Labopin M; Department of Hematology, EBMT Paris Office, CEREST-TC, Saint Antoine Hospital, Paris, France.
Daguindau E; Hôpital Jean Minjoz, Service d`Hématologie, Besançon, France.
Niittyvuopio R; HUCH Comprehensive Cancer Center, Stem Cell Transplantation Unit, Helsinki, Finland.
Huynh A; CHU - Institut Universitaire du Cancer Toulouse, Oncopole, Toulouse, France.
Socié G; Department of Hematology - BMT, Hôpital St. Louis, Paris, France.
Srour M; CHU de Lille, Université de Lille, Lille, France.
Henri Bourhis J; Department of Hematology, Gustave Roussy Cancer Campus, BMT Service, Villejuif, France.
Kröger N; University Hospital Eppendorf, Bone Marrow Transplantation Centre, Hamburg, Germany.
Tholouli E; Clinica Haematology Department, Manchester Royal Infirmary, Manchester, UK.
Choi G; Department of Hematology, University Medical Center Groningen (UMCG), University of Groningen, Groningen, The Netherlands.
Poiré X; Department of Haematology, Cliniques Universitaires St. Luc, Brussels, Belgium.
Martin H; Goethe-Universitaet, Medizinische Klinik II, Hämatologie, Medizinische Onkologie, Frankfurt, Germany.
Rubio MT; CHRU BRABOIS, Service Hématologie, Vandoeuvre-lès-Nancy, France.
Jindra P; Department of Hematology/Oncology, Charles University Hospital, Pilsen, Czech Republic.
Blaise D; Programme de Transplantation & Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Marseille, France.
Beelen D; Department of Bone Marrow Transplantation, University Hospital, Essen, Germany.
Labussière-Wallet H; Centre Hospitalier Lyon Sud, Service Hématologie, Lyon, France.
Nagler A; Hematology Division, Chaim Sheba Medical Center, Tel Hashomer, Israel.
Bazarbachi A; Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
Mohty M; Department of Hematology, EBMT Paris Office, CEREST-TC, Saint Antoine Hospital, Paris, France.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2022 Feb; Vol. 11 (4), pp. 1068-1080. Date of Electronic Publication: 2022 Jan 20.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/methods
Leukemia, Myeloid, Acute*/genetics
Leukemia, Myeloid, Acute*/therapy
Adult ; Humans ; Mutation ; Nucleophosmin ; Prognosis ; Recurrence ; Retrospective Studies ; fms-Like Tyrosine Kinase 3/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
aHSCT is superior to alemtuzumab in maintaining NEDA and improving cognition in multiple sclerosis.
Autorzy:
Häußler V; Institute of Neuroimmunology and Multiple Sclerosis, University Medical Centre Hamburg-Eppendorf, Falkenried 94, Hamburg, 20251, Germany.; Department of Neurology, University Medical Centre Hamburg-Eppendorf, Martinistraße 52, Hamburg, 20246, Germany.
Ufer F; Institute of Neuroimmunology and Multiple Sclerosis, University Medical Centre Hamburg-Eppendorf, Falkenried 94, Hamburg, 20251, Germany.; Department of Neurology, University Medical Centre Hamburg-Eppendorf, Martinistraße 52, Hamburg, 20246, Germany.
Pöttgen J; Institute of Neuroimmunology and Multiple Sclerosis, University Medical Centre Hamburg-Eppendorf, Falkenried 94, Hamburg, 20251, Germany.; Department of Neurology, University Medical Centre Hamburg-Eppendorf, Martinistraße 52, Hamburg, 20246, Germany.
Wolschke C; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistraße 52, Hamburg, 20246, Germany.
Friese MA; Institute of Neuroimmunology and Multiple Sclerosis, University Medical Centre Hamburg-Eppendorf, Falkenried 94, Hamburg, 20251, Germany.; Department of Neurology, University Medical Centre Hamburg-Eppendorf, Martinistraße 52, Hamburg, 20246, Germany.
Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Martinistraße 52, Hamburg, 20246, Germany.
Heesen C; Institute of Neuroimmunology and Multiple Sclerosis, University Medical Centre Hamburg-Eppendorf, Falkenried 94, Hamburg, 20251, Germany.; Department of Neurology, University Medical Centre Hamburg-Eppendorf, Martinistraße 52, Hamburg, 20246, Germany.
Stellmann JP; Institute of Neuroimmunology and Multiple Sclerosis, University Medical Centre Hamburg-Eppendorf, Falkenried 94, Hamburg, 20251, Germany.; Department of Neurology, University Medical Centre Hamburg-Eppendorf, Martinistraße 52, Hamburg, 20246, Germany.; APHM, Hopital de la Timone, CEMEREM, Marseille, France.; Aix Marseille Univ, CNRS, CRMBM, UMR 7339, Marseille, France.
Pokaż więcej
Źródło:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2021 Jun; Vol. 8 (6), pp. 1269-1278. Date of Electronic Publication: 2021 May 05.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Disease Progression*
Hematopoietic Stem Cell Transplantation*
Registries*
Alemtuzumab/*pharmacology
Cognitive Dysfunction/*therapy
Multiple Sclerosis/*diagnosis
Multiple Sclerosis/*therapy
Adult ; Alemtuzumab/administration & dosage ; Cognitive Dysfunction/drug therapy ; Cognitive Dysfunction/etiology ; Female ; Follow-Up Studies ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Multiple Sclerosis/complications ; Multiple Sclerosis/drug therapy ; Neuropsychological Tests ; Outcome Assessment, Health Care ; Patient Acuity ; Transplantation, Autologous ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Post-transplant cyclophosphamide containing regimens after matched sibling, matched unrelated and haploidentical donor transplants in patients with acute lymphoblastic leukemia in first complete remission, a comparative study of the ALWP of the EBMT.
Autorzy:
Sanz J; Hematology Department, Hospital Universitari i Politècnic La Fe, Valencia, Spain. sanz_.; CIBERONC, Instituto Carlos III, Madrid, Spain. sanz_.
Galimard JE; EBMT Paris Study Office, Department of Haematology, Saint Antoine Hospital, INSERM UMR 938, Sorbonne University, Paris, France.
Labopin M; EBMT Paris Study Office, Department of Haematology, Saint Antoine Hospital, INSERM UMR 938, Sorbonne University, Paris, France.
Afanasyev B; RM Gorbacheva Research Institute, Pavlov University, Lva Tolstogo 6/8, 197022, Saint-Petersburg, Russian Federation.
Sergeevich MI; RM Gorbacheva Research Institute, Pavlov University, Lva Tolstogo 6/8, 197022, Saint-Petersburg, Russian Federation.
Angelucci E; Hematology and Transplant Center, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Kröger N; Bone Marrow Transplantation Centre, University Hospital Eppendorf, Hamburg, Germany.
Koc Y; Medicana International, Istanbul, Turkey.
Ciceri F; Ospedale San Raffaele s.r.l., Haematology and BMT, Milan, Italy.
Diez-Martin JL; Hematology Department, Hospital GU Gregorio Marañon, Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutense Madrid, Madrid, Spain.
Arat M; Florence Nightingale Sisli Hospital, Hematopoietic SCT Unit, Istanbul, Turkey.
Sica S; Istituto di Ematologia, Universita Cattolica S. Cuore, Rome, Italy.
Rovira M; Department of Hematology, Hospital Clinic, Institute of Hematology and Oncology, Barcelona, Spain.; August Pi I Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
Aljurf M; King Faisal Specialist Hospital and Research Centre Oncology (Section of Adult Haematolgy/BMT), Riyadh, Saudi Arabia.
Tischer J; Department of Internal Medicine III, Grosshadern, LMU, University Hospital of Munich, Munich, Germany.
Savani B; Vanderbilt University Medical Center, Nashville, TN, USA.
Ruggeri A; Ospedale San Raffaele s.r.l., Haematology and BMT, Milan, Italy.
Nagler A; Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Tel-Hashomer, Ramat-Gan, Israel.
Mohty M; Department of Hematology, and INSERM UMRs 938, Hopital Saint Antoine, Sorbonne University, Paris, France.
Pokaż więcej
Źródło:
Journal of hematology & oncology [J Hematol Oncol] 2021 May 28; Vol. 14 (1), pp. 84. Date of Electronic Publication: 2021 May 28.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*/adverse effects
Antineoplastic Agents, Alkylating/*therapeutic use
Cyclophosphamide/*therapeutic use
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Adult ; Aged ; Female ; Graft vs Host Disease/etiology ; Graft vs Host Disease/prevention & control ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Transplantation, Haploidentical/adverse effects ; Transplantation, Homologous/adverse effects ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Patient Characteristics and Clinical Course of COVID-19 Patients Treated at a German Tertiary Center during the First and Second Waves in the Year 2020.
Autorzy:
Brehm TT; I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Germany.
Heyer A; I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
Roedl K; Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
Jarczak D; Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
Nierhaus A; Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
Nentwich MF; Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
van der Meirschen M; I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
Schultze A; Department of Emergency Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
Christner M; Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
Fiedler W; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Huber TB; III. Department of Medicine, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
Klose H; Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
Sterneck M; I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
Jordan S; I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
Kreuels B; I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
Schmiedel S; I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Germany.
Addo MM; I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Germany.
Huber S; I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
Lohse AW; I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Germany.
Kluge S; Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.
Schulze Zur Wiesch J; I. Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246 Hamburg, Germany.; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Germany.
Pokaż więcej
Źródło:
Journal of clinical medicine [J Clin Med] 2021 May 24; Vol. 10 (11). Date of Electronic Publication: 2021 May 24.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Role of pre-transplant MRD level detected by flow cytometry in recipients of allogeneic stem cell transplantation with AML.
Autorzy:
Klyuchnikov E; Department of Stem Cell Transplantation, University Medical Center Eppendorf, University of Hamburg, Hamburg, Germany.
Christopeit M; Department of Stem Cell Transplantation, University Medical Center Eppendorf, University of Hamburg, Hamburg, Germany.
Badbaran A; Department of Stem Cell Transplantation, University Medical Center Eppendorf, University of Hamburg, Hamburg, Germany.
Bacher U; Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, Bern, Switzerland.
Fritzsche-Friedland U; Department of Stem Cell Transplantation, University Medical Center Eppendorf, University of Hamburg, Hamburg, Germany.
von Pein UM; Department of Stem Cell Transplantation, University Medical Center Eppendorf, University of Hamburg, Hamburg, Germany.
Wolschke C; Department of Stem Cell Transplantation, University Medical Center Eppendorf, University of Hamburg, Hamburg, Germany.
Kröger N; Department of Stem Cell Transplantation, University Medical Center Eppendorf, University of Hamburg, Hamburg, Germany.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2021 May; Vol. 106 (5), pp. 606-615. Date of Electronic Publication: 2021 Feb 15.
Typ publikacji:
Journal Article
MeSH Terms:
Flow Cytometry*/methods
Preoperative Care*/methods
Leukemia, Myeloid, Acute/*diagnosis
Neoplasm, Residual/*diagnosis
Adult ; Aged ; Aged, 80 and over ; Bone Marrow/pathology ; Bone Marrow Cells/pathology ; Clinical Decision-Making ; Disease Management ; Female ; Hematopoietic Stem Cell Transplantation/methods ; Humans ; Leukemia, Myeloid, Acute/therapy ; Male ; Middle Aged ; Outcome Assessment, Health Care ; Transplantation, Homologous ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogenous leukemia - a study of the Acute Leukemia Working Party of the EBMT.
Autorzy:
Heinicke T; Department of Hematology and Oncology, Otto-von-Guericke University, Magdeburg, Germany.
Labopin M; Department of Hematology and Cell Therapy, Hopital Saint-Antoine, Paris, France.; Acute Leukemia Working Party of EBMT Office, Hopital St. Antoine, Paris, France.
Polge E; Acute Leukemia Working Party of EBMT Office, Hopital St. Antoine, Paris, France.
Stelljes M; Department of Internal Medicine A, University of Muenster, Muenster, Germany.
Ganser A; Department of Haematology, Hemostasis, Oncology, Hannover Medical School, Hannover, Germany.
Tischer J; Department of Internal Medicine III, Hematopoietic Stem Cell Transplantation, University Hospital of Munich-Campus Grosshadern, LMU, Munich, Germany.
Brecht A; DKD Helios-Klinikum, KMT-Abteilung, Wiesbaden, Germany.
Kröger N; Department of Stem Cell Transplantation, University Hospital Eppendorf, Hamburg, Germany.
Beelen DW; Department of Bone Marrow Transplantation, University Hospital Essen, Essen, Germany.
Scheid C; I Department of Medicine, University of Cologne, Cologne, Germany.
Bethge W; Medizinische Klinik II, University Tübingen, Tübingen, Germany.
Dreger P; Medizinische Klinik u. Poliklinik V, University of Heidelberg, Heidelberg, Germany.
Bunjes D; Klinik fuer Innere Medzin III, University Hospital Ulm, Ulm, Germany.
Wagner E; Department of Hematology, Oncology and Pneumology, University Medical Center Mainz, Mainz, Germany.
Platzbecker U; Medical Clinic and Policlinic 1, University Hospital Leipzig, Leipzig, Germany.
Savani BN; Division of Hematology-Oncology, Vanderbilt University Medical Center, Brentwood, TN, USA.
Nagler A; Acute Leukemia Working Party of EBMT Office, Hopital St. Antoine, Paris, France.; Hematology Division and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer and Tel Aviv University, Tel HaShomer, Israel.
Mohty M; Department of Hematology and Cell Therapy, Hopital Saint-Antoine, Paris, France.; Acute Leukemia Working Party of EBMT Office, Hopital St. Antoine, Paris, France.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2021 Feb; Vol. 62 (2), pp. 399-409. Date of Electronic Publication: 2020 Oct 11.
Typ publikacji:
Journal Article
MeSH Terms:
Graft vs Host Disease*
Hematopoietic Stem Cell Transplantation*
Leukemia, Myeloid, Acute*/therapy
Aged ; Busulfan ; Humans ; Middle Aged ; Retrospective Studies ; Transplantation Conditioning
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT).
Autorzy:
Saraceni F; Hematology and Stem Cell Transplant, Università Politecnica delle Marche, Ancona, Italy.
Labopin M; EBMT Paris Study Office, Saint Antoine Hospital, Paris, France.
Forcade E; CHU Bordeaux, Hôpital Haut-leveque, Pessac, France.
Kröger N; Bone Marrow Transplantation Centre, University Hospital Eppendorf, Hamburg, Germany.
Socié G; Department of Hematology - BMT, Hopital St. Louis, Paris, France.
Niittyvuopio R; HUCH Comprehensive Cancer Center, Stem Cell Transplantation Unit, Helsinki, Finland.
Cornelissen JJ; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Labussière-Wallet H; Centre Hospitalier Lyon Sud, Lyon, France.
Blaise D; Programme de Transplantation & Therapie Cellulaire, Centre de Recherche en Cancérologie de Marseille, Institut Paoli Calmettes, Marseille, France.
Choi G; University Medical Center Groningen (UMCG), Department of Hematology, University of Groningen, Groningen, The Netherlands.
Byrne JL; Nottingham University, Nottingham, United Kingdom.
Guillerm G; C.H.R.U de Brest, Service Onco-Hematologie, Brest, France.
Marchand T; Service d`Hematologie Clinique Adulte, Centre Hospitalier Universitaire de Rennes, Rennes, France.
Esteve J; Hospital Clínic, Barcelona, Spain.
Bazarbachi A; Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
Savani B; Vanderbilt University Medical Center, Nashville, TN, USA.
Olivieri A; Hematology and Stem Cell Transplant, Università Politecnica delle Marche, Ancona, Italy.
Nagler A; Department of Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Mohty M; EBMT Paris Study Office, Saint Antoine Hospital, Paris, France.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2021 Jan; Vol. 10 (1), pp. 23-33. Date of Electronic Publication: 2020 Nov 26.
Typ publikacji:
Journal Article
MeSH Terms:
Karnofsky Performance Status*
Stem Cell Transplantation*/adverse effects
Stem Cell Transplantation*/mortality
Leukemia, Myeloid, Acute/*surgery
Adult ; Clinical Decision-Making ; Disease Progression ; Female ; Graft vs Host Disease/etiology ; Humans ; Leukemia, Myeloid, Acute/diagnosis ; Leukemia, Myeloid, Acute/mortality ; Male ; Middle Aged ; Predictive Value of Tests ; Progression-Free Survival ; Recurrence ; Registries ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Time Factors ; Transplantation Conditioning ; Transplantation, Homologous
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Major central nervous system complications after allogeneic stem cell transplantation: A large retrospective study on 888 consecutive adult patients.
Autorzy:
Mannina D; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milano, Italy.
Berneking L; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Both A; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Timm W; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Urbanowicz T; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Wolschke C; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ayuketang Ayuk F; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Fischer N; Institute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; German Center for Infection Research (DZIF), Partner Site Hamburg-Borstel-Lübeck, Hamburg, Germany.
Fiehler J; Department of Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Grzyska U; Department of Neuroradiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Rösner S; Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Choe CU; Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kröger N; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Christopeit M; Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2020 Dec; Vol. 105 (6), pp. 722-730. Date of Electronic Publication: 2020 Sep 27.
Typ publikacji:
Journal Article
MeSH Terms:
Central Nervous System Diseases/*epidemiology
Central Nervous System Diseases/*etiology
Hematopoietic Stem Cell Transplantation/*adverse effects
Adult ; Central Nervous System Diseases/diagnosis ; Disease Susceptibility ; Female ; Hematopoietic Stem Cell Transplantation/methods ; Hematopoietic Stem Cell Transplantation/statistics & numerical data ; Humans ; Incidence ; Male ; Morbidity ; Mortality ; Prognosis ; Recurrence ; Retrospective Studies ; Risk Factors ; Transplantation, Homologous
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Treosulfan-Based Conditioning Regimen for Second Allograft in Patients with Myelofibrosis.
Autorzy:
Atagunduz IK; Hematology Department, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.; Hematology Department, Marmara University Pendik Training and Research Hospital, 34899 Istanbul, Turkey.
Klyuchnikov E; Hematology Department, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Wolschke C; Hematology Department, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Janson D; Hematology Department, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Heidenreich S; Hematology Department, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Christopeit M; Hematology Department, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Ayuk F; Hematology Department, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Kröger N; Hematology Department, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2020 Oct 23; Vol. 12 (11). Date of Electronic Publication: 2020 Oct 23.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Monocenter study on epidemiology, outcomes, and risk factors of infections in recipients of 166 allogeneic stem cell transplantations during 1 year.
Autorzy:
Samek M; Department of Stem Cell Transplantation, University Medical Center Eppendorf, Hamburg, Germany.
Iversen K; Department of Stem Cell Transplantation, University Medical Center Eppendorf, Hamburg, Germany.
Belmar Campos C; Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Eppendorf, Hamburg, Germany.
Berneking L; Institute of Medical Microbiology, Virology and Hygiene, University Medical Center Eppendorf, Hamburg, Germany.
Langebrake C; Department of Stem Cell Transplantation, University Medical Center Eppendorf, Hamburg, Germany.; Pharmacy, University Medical Center Eppendorf, Hamburg, Germany.
Wolschke C; Department of Stem Cell Transplantation, University Medical Center Eppendorf, Hamburg, Germany.
Ayuk F; Department of Stem Cell Transplantation, University Medical Center Eppendorf, Hamburg, Germany.
Kröger N; Department of Stem Cell Transplantation, University Medical Center Eppendorf, Hamburg, Germany.
Christopeit M; Department of Stem Cell Transplantation, University Medical Center Eppendorf, Hamburg, Germany.
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2020 Aug; Vol. 105 (2), pp. 126-137. Date of Electronic Publication: 2020 May 28.
Typ publikacji:
Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation/*adverse effects
Hematopoietic Stem Cell Transplantation/*statistics & numerical data
Infections/*epidemiology
Infections/*etiology
Adolescent ; Adult ; Aged ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use ; Disease Management ; Disease Susceptibility ; Female ; Health Care Surveys ; Hematopoietic Stem Cell Transplantation/methods ; Humans ; Incidence ; Infections/diagnosis ; Infections/drug therapy ; Male ; Middle Aged ; Neutropenia/complications ; Neutropenia/epidemiology ; Neutropenia/etiology ; Risk Assessment ; Risk Factors ; Transplantation, Homologous ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 73

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies